Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. - Wikidata - wikimedia - TriplyDB

Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study.

Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study.

http://www.wikidata.org/entity/Q30843640

about

Current application of proteomics in biomarker discovery for inflammatory bowel disease Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.New proteomic approaches for biomarker discovery in inflammatory bowel disease.Identification of microRNAs associated with ileal and colonic Crohn's disease Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.Serum protein profiling of adults and children with Crohn disease.Dysregulation of anti-inflammatory annexin A1 expression in progressive Crohns Disease Biomarkers in inflammatory bowel disease: current practices and recent advances.Serum Proteome Profiles in Stricturing Crohn's Disease: A Pilot Study.Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies.New serological biomarkers of inflammatory bowel disease.Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.Proteomics at the interface of psychology, gut physiology and dysfunction: an underexploited approach that deserves expansion.Current advantages in the application of proteomics in inflammatory bowel disease.Mining protein lists from proteomics studies: applications for drug discovery.Genomics and proteomics: Applications in autoimmune diseases.Proteomics and metabolomics in inflammatory bowel disease.Towards personalized care in IBD.New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.Utility of Biomarkers in the Management of Inflammatory Bowel Disease.Update on current applications of proteomic in the study of inflammatory bowel disease.Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse.Serum protein profile of Crohn's disease treated with infliximab.Proteomics of Children Born After Intracytoplasmic Sperm Injection Reveal Indices of an Adverse Cardiometabolic Profile.Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease.

P2860

Q28078755-311D0C35-EB7F-4225-8584-6D4F9D12E46D Q30468972-0B317A5E-C08D-466D-B5FE-783B11E9D0C7 Q33355906-F4CAD85F-6EA2-4C31-BDDE-FA85B2B2A5EE Q33520447-029383EE-CD7A-40E7-85F5-A61B1771E4A0 Q34096526-FE48AD5F-83E6-460A-9DA4-D8CF60E13A34 Q34159093-4A41E054-BEBF-4710-89C0-44A8885FF706 Q34413480-7777B2AF-5B2E-4FCF-AAA8-6D9423FEED63 Q34772207-DE30AA84-18B3-4DCD-8FC2-B579FBFEE518 Q35018662-EC4FC507-6868-471B-BD79-AFB22C877FA6 Q35840853-8EFD3E0F-6201-410C-BCAD-BA8EEE3E4257 Q35880979-430B1688-4EC7-4A48-800E-40AA597B8F85 Q36052700-77683A65-670E-4D6A-845C-8AAC462A3528 Q37155926-96DC3275-16B0-4FC3-A1A7-713A34003CC8 Q37262989-2D09E9C7-EDDB-4631-AF7E-935B33639AFC Q37672624-63258BF6-396B-4F5D-8537-29655D767FD6 Q37945789-02A634C9-6F15-44C4-87C5-9D756921AE34 Q38022190-2B621BD5-6BF6-456D-BB0D-6B174A6438F7 Q38028539-A050D920-41C5-4DBE-91C5-9C10AE0604C8 Q38066181-EB28687C-8FA9-498C-869E-BC9664A2FFC4 Q38089179-1A77FE4D-272F-46C0-9867-3BEFCEC55925 Q38171924-DC22ED98-D677-4564-AF89-449B30AADAA8 Q38986222-484381CD-9E32-4694-8CB3-6168E27408BB Q39110763-A9758CAD-33F2-48A5-9D53-BF6535C725F7 Q42406649-B03DC9A6-8E20-410F-BCF3-9182602F31B4 Q43988900-D0B136EA-A0F3-44E4-89B1-7D4FDDA72F1A Q45886414-01E2635A-478A-49F9-B96D-19BD8784895F Q52741486-2132A12B-CBF6-4346-937B-BBE664496DF4 Q53264356-D522ACB9-29F8-49B9-9D03-7769E88E7C01

P2860

Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study.

http://www.wikidata.org/entity/Q30843640

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Proteomics for prediction and ...... rohn's disease: a pilot study.

@ast

Proteomics for prediction and ...... rohn's disease: a pilot study.

@en

type

label

Proteomics for prediction and ...... rohn's disease: a pilot study.

@ast

Proteomics for prediction and ...... rohn's disease: a pilot study.

@en

prefLabel

Proteomics for prediction and ...... rohn's disease: a pilot study.

@ast

Proteomics for prediction and ...... rohn's disease: a pilot study.

@en

P1433

Q30843640-EA443B3D-1FDC-476A-AA24-E3D200C8E9FC

P1476

Q30843640-6D65925C-873E-46E5-87B2-6FC687A93A0B

P2093

Q30843640-19C916CC-3D21-45DE-9A75-0E14E9A14132

Q30843640-46686FC7-57AC-4F57-9065-2E176F3FD6C7

Q30843640-49FF3E1E-A18C-47C5-8213-24CC0BE64187

Q30843640-7073AB27-1AC5-44C7-905A-CE1B2508CAC9

Q30843640-7231D722-DDC5-4315-BED4-154096025FA4

Q30843640-875124B5-969E-4D33-BEBB-FFC7FED37E7C

Q30843640-93783205-207B-42F1-83E6-D03DDBAD317A

Q30843640-9F15C7A3-474E-448D-816C-6B417A978BEE

Q30843640-A6C7F83F-B111-4419-BA70-60C890C1D8A9

Q30843640-BB8DA7C8-5B5A-46BE-8039-844F808DCE48

P304

Q30843640-FA9AA878-35AA-4F76-93FA-F896EAD76C0B

P31

Q30843640-3D95FDB7-45C4-4535-928D-E88605532B4F

P356

Q30843640-31C31CAE-0471-421C-A4A2-C30CCFE72F40

P433

Q30843640-02118F64-A183-4DEB-AA47-2396989A1441

P478

Q30843640-45638BB8-D73A-4063-A98A-8C4874B147D4

P50

Q30843640-4AEF5C84-566F-470F-A571-6A1AB0962A9D

Q30843640-EB9CD1AC-1EAF-426C-ACF8-D4C761B898C1

P577

Q30843640-8C161997-61EC-40EA-84E8-12D62383E42B

P5875

Q30843640-9EA676E8-1AB6-4DFA-A6E3-DCC7689981B5

P698

Q30843640-07031204-1E42-405C-A88F-11A9B49FE6C8

P921

Q30843640-6A2004B7-BBB8-456C-B3D5-34470DE931DB

P356

J.CLINBIOCHEM.2008.04.021

P1433

Clinical Biochemistry

P1476

Proteomics for prediction and ...... rohn's disease: a pilot study.

@en

P2093

Dominique de Seny

http://www.w3.org/2001/XMLSchema#string

Edouard Louis

http://www.w3.org/2001/XMLSchema#string

Jacques Belaiche

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Chapelle

http://www.w3.org/2001/XMLSchema#string

Laurence Lutteri

http://www.w3.org/2001/XMLSchema#string

Louis Wehenkel

http://www.w3.org/2001/XMLSchema#string

Marianne Fillet

http://www.w3.org/2001/XMLSchema#string

Marie-Paule Merville

http://www.w3.org/2001/XMLSchema#string

Michel Malaise

http://www.w3.org/2001/XMLSchema#string

Pierre Geurts

http://www.w3.org/2001/XMLSchema#string

P304

960-967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLINBIOCHEM.2008.04.021

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

Marie-Alice Meuwis

Marie-Paule Merville

P577

2008-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5360353

http://www.w3.org/2001/XMLSchema#string

P698

18489908

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease